Analyzing the options chain of IOVA Iovance Biotherapeutics prior to the earnings report this week, I would consider purchasing the 7.5usd strike price Puts with an expiration date of 2023-6-16, for a premium of approximately $0.70 If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
Operación cerrada: objetivo alcanzado
⋅
IOVA trading at $7.97 after earnings and calls at $1.10, from $0.70 when I wrote this article. About 60% gain!
Operación activa
⋅
Iovance Biotherapeutics has made an announcement regarding the acceptance of the Biologics License Application by the U.S. Food and Drug Administration for Lifileucel, a treatment intended for advanced melanoma.
you bought puts as mentioned, and the calls are profitable in ur update, am i missing something?
TopgOptions
⋅
@BUMISHO, that was an error in my post. I wanted to say calls. as you can see in the chart, it was a double bottom and an arrow indicating up and a strike price that wasn`t reached yet, right? and when you bought the puts, haven`t you noticed that the price was different, and in fact, the premium that I mentioned was the one for the $7.5 strike price calls? and most important don`t follow my signals, because they are only personal opinions, you need to do your own research before investing. especially in the options market, which is extremely volatile!
BUMISHO
⋅
@TopgOptions,As you said its all clear in the chart, i just wanted to make it clear to myself and the readers that the descriptions goes well with the chart as your page is a reference to me and i realy admire your work.
Keep up the good work and good luck
TopgOptions
⋅
@BUMISHO, thank you so much for your kind words. I really appreciate it. I am sorry for the confusion created by the post.